Detalhe da pesquisa
1.
Preoperative Strategies for Locally Advanced Colon Cancer.
Curr Treat Options Oncol
; 25(3): 376-388, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349502
2.
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
Invest New Drugs
; 39(1): 142-151, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556884
3.
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
Invest New Drugs
; 34(1): 84-95, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26620496
4.
Evolving Standards of Care in the Management of Localized Colorectal Cancer.
Am Soc Clin Oncol Educ Book
; 44(3): e432034, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768426
5.
Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer.
Sci Rep
; 14(1): 4294, 2024 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383634
6.
Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.
Cancer Med
; 12(6): 7327-7338, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621839
7.
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
JAMA Oncol
; 9(3): 404-413, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701146
8.
Racial disparities negatively impact outcomes in early-onset colorectal cancer independent of socioeconomic status.
Cancer Med
; 10(21): 7542-7550, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647438
9.
A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer.
J Gastrointest Oncol
; 12(3): 910-920, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295544
10.
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.
Cancer Res
; 80(21): 4815-4827, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907836
11.
Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
Surgery
; 142(4): 581-6; discussion 586-7, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17950351
12.
A Blueprint to Advance Colorectal Cancer Immunotherapies.
Cancer Immunol Res
; 5(11): 942-949, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038296
13.
The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients.
PLoS One
; 9(9): e107993, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25238395
14.
The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases.
Cancer Chemother Pharmacol
; 72(1): 53-64, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23719718
15.
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 70(4): 547-53, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22868341
16.
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Clin Colorectal Cancer
; 11(1): 53-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813336
17.
Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.
Clin Cancer Res
; 18(4): 1092-100, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22179664
18.
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol
; 34(9): 987-1011, 2016 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846975
19.
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers.
Clin Cancer Res
; 16(6): 1924-37, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20215549
20.
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
Cancer Chemother Pharmacol
; 63(5): 851-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18670776